| Title |
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
|
|---|---|
| Published in |
Neurotherapeutics, January 2020
|
| DOI | 10.1007/s13311-019-00775-8 |
| Pubmed ID | |
| Authors |
Karen Henriette Pinke, Sofia Fernanda Gonçalves Zorzella-Pezavento, Thais Fernanda de Campos Fraga-Silva, Luiza Ayumi Nishiyama Mimura, Larissa Ragozo Cardoso de Oliveira, Larissa Lumi Watanabe Ishikawa, Ana Angélica Henrique Fernandes, Vanessa Soares Lara, Alexandrina Sartori |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 29% |
| Curaçao | 1 | 14% |
| Brazil | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Science communicators (journalists, bloggers, editors) | 1 | 14% |
| Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 38 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 9 | 24% |
| Researcher | 8 | 21% |
| Student > Master | 3 | 8% |
| Professor > Associate Professor | 2 | 5% |
| Student > Doctoral Student | 1 | 3% |
| Other | 4 | 11% |
| Unknown | 11 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 5 | 13% |
| Medicine and Dentistry | 5 | 13% |
| Neuroscience | 3 | 8% |
| Nursing and Health Professions | 3 | 8% |
| Agricultural and Biological Sciences | 1 | 3% |
| Other | 6 | 16% |
| Unknown | 15 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2024.
All research outputs
#4,630,346
of 25,840,929 outputs
Outputs from Neurotherapeutics
#487
of 1,321 outputs
Outputs of similar age
#101,467
of 480,541 outputs
Outputs of similar age from Neurotherapeutics
#11
of 26 outputs
Altmetric has tracked 25,840,929 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,321 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.7. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 480,541 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.